Programs

All Programs

Use the tool below to view all available Global Oncology Academy Series

- Nichole Tanner, MD, MS, FCCP
  Peer
- Eric Edell, MD, FCCP
  Peer
- Septimiu Murgu, MD, FCCP
  Peer
0
CME/CE
Lung Cancer Screening and What to do When a Nodule is Detected
Lung Cancer Screening and What to do When a Nodule is Detected
0.25 credits
Lung Cancer Screening and What to do When a Nodule is Detected
0.25 credits
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Douglas Rex, MD
  Peer
0
Clinician's Roundtable
Improving Early Detection of CRC with the Latest Screening Recommendations
Improving Early Detection of CRC with the Latest Screening Recommendations
Improving Early Detection of CRC with the Latest Screening Recommendations
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ehab L. Atallah, MD
  Peer
1
Project Oncology®
Evolutions of the CLL Treatment Paradigm: A Look at Long-Term Data
Evolutions of the CLL Treatment Paradigm: A Look at Long-Term Data
Evolutions of the CLL Treatment Paradigm: A Look at Long-Term Data
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
1
CME/CE
Multiple Myeloma: Updates from ASCO 2022
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
Multiple Myeloma: Updates from ASCO 2022
0.25 credits
- Jacob D. Soumerai, MD
  Peer
- Andrew H. Lipsky, MD
  Peer
2
CME/CE
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
0.25 credits
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
1
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
0.25 credits
- Amrita Krishnan, MD
  Peer
- Morie Gertz, MD, MACP
  Peer
3
CME/CE
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
0.25 credits
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Rel…
0.25 credits
- Caitlin Costello, MD
  Peer
2
Oncology and Hematology
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
Patients as Partners in Multiple Myeloma: What to Ask and What to Expect
- Pavani Chalasani MD, MPH
  Peer
- Seema A. Khan, MD
  Peer
0
Project Oncology®
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
Treating Metastatic Breast Cancer: Where Are We Now?
- Elizabeth Smyth, MD
  Peer
- Jaffer Ajani, MD
  Peer
4
CME/CE
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GEJ Cancers
0.25 credits
Optimal Standards of Care for Second-Line HER2-Positive Advanced Gastric and GE…
0.25 credits
- Pavani Chalasani MD, MPH
  Peer
- Kevin Kalinsky MD, MS
  Peer
0
Project Oncology®
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
Conversations Around Chemotherapy: Do All of Your Patients Need It?
- Sagar Lonial, MD, FACP
  Peer
- Noopur Raje, MD
  Peer
3
CME/CE
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits
Novel Clinical Approaches in Multiple Myeloma: CAR T Cell Therapy
0.25 credits
- Lyudmila Bazhenova, MD
  Peer
- Benjamin Levy, MD
  Peer
7
CME/CE
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
The Emerging Role of HER2 (ERBB2) Mutations in NSCLC
0.25 credits
- Pavani Chalasani MD, MPH
  Peer
- Aditya Bardia, MD, MPH
  Peer
0
Project Oncology®
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
- Jacqueline Garcia, MD
  Peer
- David A. Sallman, MD
  Peer
4
CME/CE
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Stratifying MDS
0.25 credits
Keeping Pace with Hematologic Malignancies: Understanding, Classifying, and Str…
0.25 credits
- Larry Anderson, MD, PhD
  Peer
- Thomas G. Martin, MD
  Peer
3
CME/CE
State of the Union: CAR T Cell Therapy
State of the Union: CAR T Cell Therapy
0.25 credits
State of the Union: CAR T Cell Therapy
0.25 credits

Popular

CME/CE

Clinician's Roundtable

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

Oncology and Hematology

Project Oncology®

CME/CE

Project Oncology®

CME/CE

CME/CE

Project Oncology®

CME/CE

CME/CE

NEED HELP?

Contact us

NEED HELP?

Contact us

Popular

CME/CE

Clinician's Roundtable

Project Oncology®

CME/CE

CME/CE

CME/CE

CME/CE

Oncology and Hematology

Project Oncology®

CME/CE

Project Oncology®

CME/CE

CME/CE

Project Oncology®

CME/CE

CME/CE

Title

Share on ReachMD

Get a Dose of Global Oncology Academy in Your Inbox and Practice Smarter Medicine

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.